Generic Statins Make Sense In Lower CV Risk Patients, WellPoint Asserts
Generic statins can provide equal cardiovascular benefits - particularly in patients with low to moderate risk of cardiovascular events - while offering substantial cost savings over brand-name drugs, according to a study recently released by WellPoint
You may also be interested in...
Citing improved rebate terms, Express Scripts is including Pfizer's Lipitor on its National Preferred Formulary for the first time since January 2006
WellPoint beneficiaries will be able to receive up to four months of generic simvastatin as an incentive to switch from a branded cholesterol-lowering agent
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.